Financhill
Sell
30

BUDZ Quote, Financials, Valuation and Earnings

Last price:
$0.04
Seasonality move :
31.92%
Day range:
$0.04 - $0.05
52-week range:
$0.02 - $0.08
Dividend yield:
0%
P/E ratio:
180.00x
P/S ratio:
--
P/B ratio:
887.06x
Volume:
154.2K
Avg. volume:
144.5K
1-year change:
34.68%
Market cap:
$5.9M
Revenue:
--
EPS (TTM):
-$0.01

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
BUDZ
WEED, Inc.
-- -- -- -- --
CAH
Cardinal Health, Inc.
$64.9B $2.30 17.4% 39.48% $216.60
COR
Cencora, Inc.
$86.1B $3.97 5.68% 58.76% $387.93
LAB
Standard BioTools, Inc.
$18.5M -$0.03 -60.4% -72.53% $1.65
MCK
McKesson Corp.
$106B $9.28 11.22% 33.59% $939.33
PNPL
Pineapple, Inc.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
BUDZ
WEED, Inc.
$0.04 -- $5.9M 180.00x $0.00 0% --
CAH
Cardinal Health, Inc.
$205.50 $216.60 $48.8B 31.02x $0.51 0.99% 0.21x
COR
Cencora, Inc.
$337.75 $387.93 $65.5B 42.47x $0.60 0.67% 0.20x
LAB
Standard BioTools, Inc.
$1.28 $1.65 $492.2M -- $0.00 0% 3.77x
MCK
McKesson Corp.
$820.29 $939.33 $101.2B 25.54x $0.82 0.37% 0.27x
PNPL
Pineapple, Inc.
$0.1300 -- $9.5M -- $0.00 0% 85.85x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
BUDZ
WEED, Inc.
-218.86% 0.084 5.96% 0.00x
CAH
Cardinal Health, Inc.
146.79% 0.315 24.08% 0.46x
COR
Cencora, Inc.
86.09% -0.278 15.33% 0.54x
LAB
Standard BioTools, Inc.
6.41% 0.680 5.49% 1.93x
MCK
McKesson Corp.
121.59% -0.233 10.1% 0.48x
PNPL
Pineapple, Inc.
163.34% 5.583 91.37% 0.25x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
BUDZ
WEED, Inc.
-$8.2K -$66.9K -7506.96% -- -- -$5K
CAH
Cardinal Health, Inc.
$2.2B $771M 31.66% -- 1.21% $865M
COR
Cencora, Inc.
$2.6B $854.6M 17.24% 124.72% 1.02% $2.9B
LAB
Standard BioTools, Inc.
$9.5M -$23.5M -22.34% -24.44% -120.02% -$23.1M
MCK
McKesson Corp.
$3.3B $1.4B 59.37% -- 1.36% $2.2B
PNPL
Pineapple, Inc.
-$1.7K -$1.8K -5.96% -- -138.46% -$2.4K

WEED, Inc. vs. Competitors

  • Which has Higher Returns BUDZ or CAH?

    Cardinal Health, Inc. has a net margin of -- compared to WEED, Inc.'s net margin of 0.71%. WEED, Inc.'s return on equity of -- beat Cardinal Health, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BUDZ
    WEED, Inc.
    -- -$0.00 -$162.8K
    CAH
    Cardinal Health, Inc.
    3.49% $1.88 $6.3B
  • What do Analysts Say About BUDZ or CAH?

    WEED, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Cardinal Health, Inc. has an analysts' consensus of $216.60 which suggests that it could grow by 5.4%. Given that Cardinal Health, Inc. has higher upside potential than WEED, Inc., analysts believe Cardinal Health, Inc. is more attractive than WEED, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BUDZ
    WEED, Inc.
    0 0 0
    CAH
    Cardinal Health, Inc.
    10 4 0
  • Is BUDZ or CAH More Risky?

    WEED, Inc. has a beta of 0.647, which suggesting that the stock is 35.301% less volatile than S&P 500. In comparison Cardinal Health, Inc. has a beta of 0.644, suggesting its less volatile than the S&P 500 by 35.629%.

  • Which is a Better Dividend Stock BUDZ or CAH?

    WEED, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cardinal Health, Inc. offers a yield of 0.99% to investors and pays a quarterly dividend of $0.51 per share. WEED, Inc. pays -- of its earnings as a dividend. Cardinal Health, Inc. pays out 31.43% of its earnings as a dividend. Cardinal Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BUDZ or CAH?

    WEED, Inc. quarterly revenues are --, which are smaller than Cardinal Health, Inc. quarterly revenues of $64B. WEED, Inc.'s net income of -$73.9K is lower than Cardinal Health, Inc.'s net income of $454M. Notably, WEED, Inc.'s price-to-earnings ratio is 180.00x while Cardinal Health, Inc.'s PE ratio is 31.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WEED, Inc. is -- versus 0.21x for Cardinal Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BUDZ
    WEED, Inc.
    -- 180.00x -- -$73.9K
    CAH
    Cardinal Health, Inc.
    0.21x 31.02x $64B $454M
  • Which has Higher Returns BUDZ or COR?

    Cencora, Inc. has a net margin of -- compared to WEED, Inc.'s net margin of -0.4%. WEED, Inc.'s return on equity of -- beat Cencora, Inc.'s return on equity of 124.72%.

    Company Gross Margin Earnings Per Share Invested Capital
    BUDZ
    WEED, Inc.
    -- -$0.00 -$162.8K
    COR
    Cencora, Inc.
    3.11% -$1.75 $11.1B
  • What do Analysts Say About BUDZ or COR?

    WEED, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Cencora, Inc. has an analysts' consensus of $387.93 which suggests that it could grow by 14.86%. Given that Cencora, Inc. has higher upside potential than WEED, Inc., analysts believe Cencora, Inc. is more attractive than WEED, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BUDZ
    WEED, Inc.
    0 0 0
    COR
    Cencora, Inc.
    10 4 0
  • Is BUDZ or COR More Risky?

    WEED, Inc. has a beta of 0.647, which suggesting that the stock is 35.301% less volatile than S&P 500. In comparison Cencora, Inc. has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.595%.

  • Which is a Better Dividend Stock BUDZ or COR?

    WEED, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cencora, Inc. offers a yield of 0.67% to investors and pays a quarterly dividend of $0.60 per share. WEED, Inc. pays -- of its earnings as a dividend. Cencora, Inc. pays out 27.63% of its earnings as a dividend. Cencora, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BUDZ or COR?

    WEED, Inc. quarterly revenues are --, which are smaller than Cencora, Inc. quarterly revenues of $83.7B. WEED, Inc.'s net income of -$73.9K is higher than Cencora, Inc.'s net income of -$333.1M. Notably, WEED, Inc.'s price-to-earnings ratio is 180.00x while Cencora, Inc.'s PE ratio is 42.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WEED, Inc. is -- versus 0.20x for Cencora, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BUDZ
    WEED, Inc.
    -- 180.00x -- -$73.9K
    COR
    Cencora, Inc.
    0.20x 42.47x $83.7B -$333.1M
  • Which has Higher Returns BUDZ or LAB?

    Standard BioTools, Inc. has a net margin of -- compared to WEED, Inc.'s net margin of -162.05%. WEED, Inc.'s return on equity of -- beat Standard BioTools, Inc.'s return on equity of -24.44%.

    Company Gross Margin Earnings Per Share Invested Capital
    BUDZ
    WEED, Inc.
    -- -$0.00 -$162.8K
    LAB
    Standard BioTools, Inc.
    48.51% -$0.09 $427M
  • What do Analysts Say About BUDZ or LAB?

    WEED, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 21.09%. Given that Standard BioTools, Inc. has higher upside potential than WEED, Inc., analysts believe Standard BioTools, Inc. is more attractive than WEED, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BUDZ
    WEED, Inc.
    0 0 0
    LAB
    Standard BioTools, Inc.
    1 2 0
  • Is BUDZ or LAB More Risky?

    WEED, Inc. has a beta of 0.647, which suggesting that the stock is 35.301% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.264, suggesting its more volatile than the S&P 500 by 26.42%.

  • Which is a Better Dividend Stock BUDZ or LAB?

    WEED, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. WEED, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BUDZ or LAB?

    WEED, Inc. quarterly revenues are --, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. WEED, Inc.'s net income of -$73.9K is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, WEED, Inc.'s price-to-earnings ratio is 180.00x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WEED, Inc. is -- versus 3.77x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BUDZ
    WEED, Inc.
    -- 180.00x -- -$73.9K
    LAB
    Standard BioTools, Inc.
    3.77x -- $19.6M -$31.7M
  • Which has Higher Returns BUDZ or MCK?

    McKesson Corp. has a net margin of -- compared to WEED, Inc.'s net margin of 1.13%. WEED, Inc.'s return on equity of -- beat McKesson Corp.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BUDZ
    WEED, Inc.
    -- -$0.00 -$162.8K
    MCK
    McKesson Corp.
    3.19% $8.92 $9.2B
  • What do Analysts Say About BUDZ or MCK?

    WEED, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand McKesson Corp. has an analysts' consensus of $939.33 which suggests that it could grow by 14.51%. Given that McKesson Corp. has higher upside potential than WEED, Inc., analysts believe McKesson Corp. is more attractive than WEED, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BUDZ
    WEED, Inc.
    0 0 0
    MCK
    McKesson Corp.
    10 3 0
  • Is BUDZ or MCK More Risky?

    WEED, Inc. has a beta of 0.647, which suggesting that the stock is 35.301% less volatile than S&P 500. In comparison McKesson Corp. has a beta of 0.408, suggesting its less volatile than the S&P 500 by 59.158%.

  • Which is a Better Dividend Stock BUDZ or MCK?

    WEED, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. McKesson Corp. offers a yield of 0.37% to investors and pays a quarterly dividend of $0.82 per share. WEED, Inc. pays -- of its earnings as a dividend. McKesson Corp. pays out 10.69% of its earnings as a dividend. McKesson Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BUDZ or MCK?

    WEED, Inc. quarterly revenues are --, which are smaller than McKesson Corp. quarterly revenues of $103.2B. WEED, Inc.'s net income of -$73.9K is lower than McKesson Corp.'s net income of $1.2B. Notably, WEED, Inc.'s price-to-earnings ratio is 180.00x while McKesson Corp.'s PE ratio is 25.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WEED, Inc. is -- versus 0.27x for McKesson Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BUDZ
    WEED, Inc.
    -- 180.00x -- -$73.9K
    MCK
    McKesson Corp.
    0.27x 25.54x $103.2B $1.2B
  • Which has Higher Returns BUDZ or PNPL?

    Pineapple, Inc. has a net margin of -- compared to WEED, Inc.'s net margin of -184.62%. WEED, Inc.'s return on equity of -- beat Pineapple, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BUDZ
    WEED, Inc.
    -- -$0.00 -$162.8K
    PNPL
    Pineapple, Inc.
    -130.77% -- $4.9M
  • What do Analysts Say About BUDZ or PNPL?

    WEED, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pineapple, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that WEED, Inc. has higher upside potential than Pineapple, Inc., analysts believe WEED, Inc. is more attractive than Pineapple, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BUDZ
    WEED, Inc.
    0 0 0
    PNPL
    Pineapple, Inc.
    0 0 0
  • Is BUDZ or PNPL More Risky?

    WEED, Inc. has a beta of 0.647, which suggesting that the stock is 35.301% less volatile than S&P 500. In comparison Pineapple, Inc. has a beta of 41.025, suggesting its more volatile than the S&P 500 by 4002.548%.

  • Which is a Better Dividend Stock BUDZ or PNPL?

    WEED, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pineapple, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. WEED, Inc. pays -- of its earnings as a dividend. Pineapple, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BUDZ or PNPL?

    WEED, Inc. quarterly revenues are --, which are smaller than Pineapple, Inc. quarterly revenues of $1.3K. WEED, Inc.'s net income of -$73.9K is lower than Pineapple, Inc.'s net income of -$2.4K. Notably, WEED, Inc.'s price-to-earnings ratio is 180.00x while Pineapple, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WEED, Inc. is -- versus 85.85x for Pineapple, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BUDZ
    WEED, Inc.
    -- 180.00x -- -$73.9K
    PNPL
    Pineapple, Inc.
    85.85x -- $1.3K -$2.4K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Sell
50
NUTX alert for Jan 1

Nutex Health, Inc. [NUTX] is down 9.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock